262 related articles for article (PubMed ID: 18678353)
1. Radiolabeling of annexin A5 with (99m)Tc: comparison of HYNIC-Tc vs. iminothiolane-Tc-tricarbonyl conjugates.
Biechlin ML; Bonmartin A; Gilly FN; Fraysse M; du Moulinet d'Hardemare A
Nucl Med Biol; 2008 Aug; 35(6):679-87. PubMed ID: 18678353
[TBL] [Abstract][Full Text] [Related]
2. Radiolabeling of HYNIC-annexin V with technetium-99m for in vivo imaging of apoptosis.
Blankenberg FG; Vanderheyden JL; Strauss HW; Tait JF
Nat Protoc; 2006; 1(1):108-10. PubMed ID: 17406220
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of leukotriene B4 antagonists labeled with In-111 or Tc-99m to image infectious and inflammatory foci.
Broekema M; van Eerd JJ; Oyen WJ; Corstens FH; Liskamp RM; Boerman OC; Harris TD
J Med Chem; 2005 Oct; 48(20):6442-53. PubMed ID: 16190770
[TBL] [Abstract][Full Text] [Related]
4. Confirmation of hydrazone formation in HYNIC-peptide conjugate preparation, and its hydrolysis during labeling with (99m)Tc.
Gandomkar M; Najafi R; Shafiei M; Ebrahimi SE
Appl Radiat Isot; 2007 Jul; 65(7):805-8. PubMed ID: 17467277
[TBL] [Abstract][Full Text] [Related]
5. Chemoselective hydrazone formation between HYNIC-functionalized peptides and (18)F-fluorinated aldehydes.
Bruus-Jensen K; Poethko T; Schottelius M; Hauser A; Schwaiger M; Wester HJ
Nucl Med Biol; 2006 Feb; 33(2):173-83. PubMed ID: 16546671
[TBL] [Abstract][Full Text] [Related]
6. Pre-clinical evaluation of a new indirectly labeled ⁹⁹mTc-6-hydrazinopyridine-3-carboxylic acid (HYNIC)-depreotide with HYNIC as bifunctional chelator.
Yu F; Lü ML; Zhang XP; Fu D; Hou M; Cai HD; Li D; Wang J; Yuan XY; Lü ZW; Dong F
Chin Med J (Engl); 2012 Jul; 125(14):2538-42. PubMed ID: 22882936
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of 99mTc-MAG3-annexin V: influence of the chelate on in vitro and in vivo properties in mice.
Vanderheyden JL; Liu G; He J; Patel B; Tait JF; Hnatowich DJ
Nucl Med Biol; 2006 Jan; 33(1):135-44. PubMed ID: 16459269
[TBL] [Abstract][Full Text] [Related]
8. Preliminary in vivo evaluation of a novel 99mTc-labeled HYNIC-cys-annexin A5 as an apoptosis imaging agent.
Fonge H; de Saint Hubert M; Vunckx K; Rattat D; Nuyts J; Bormans G; Ni Y; Reutelingsperger C; Verbruggen A
Bioorg Med Chem Lett; 2008 Jul; 18(13):3794-8. PubMed ID: 18524580
[TBL] [Abstract][Full Text] [Related]
9. Efficient site-specific radiolabeling of a modified C2A domain of synaptotagmin I with [99mTc(CO)3]+: a new radiopharmaceutical for imaging cell death.
Tavaré R; Torres Martin De Rosales R; Blower PJ; Mullen GE
Bioconjug Chem; 2009 Nov; 20(11):2071-81. PubMed ID: 19874007
[TBL] [Abstract][Full Text] [Related]
10. A technetium intermediate specifically promotes deprotection of trifluoroacetyl HYNIC during radiolabelling under mild conditions.
Surfraz MB; Biagini SC; Blower PJ
Dalton Trans; 2008 Jun; (22):2920-2. PubMed ID: 18493625
[TBL] [Abstract][Full Text] [Related]
11. N,N-bis(2-mercaptoethyl)methylamine: a new coligand for Tc-99m labeling of hydrazinonicotinamide peptides.
Banerjee SR; Maresca KP; Stephenson KA; Valliant JF; Babich JW; Graham WA; Barzana M; Dong Q; Fischman AJ; Zubieta J
Bioconjug Chem; 2005; 16(4):885-902. PubMed ID: 16029030
[TBL] [Abstract][Full Text] [Related]
12. Trifluoroacetyl-HYNIC peptides: synthesis and 99mTc radiolabeling.
Surfraz MB; King R; Mather SJ; Biagini SC; Blower PJ
J Med Chem; 2007 Mar; 50(6):1418-22. PubMed ID: 17315986
[TBL] [Abstract][Full Text] [Related]
13. A critical quantum chemical and experimental study of the potentiality of direct labeling of the CN group with [(99m)Tc(CO)(3)](+) or [(186/188)Re(CO)(3)](+) in CN containing biomolecules.
Safi B; Mertens J; Kersemans K; Geerlings P
Nucl Med Biol; 2008 Oct; 35(7):747-53. PubMed ID: 18848659
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT.
Li F; Cheng T; Dong Q; Wei R; Zhang Z; Luo D; Ma X; Wang S; Gao Q; Ma D; Zhu X; Xi L
Nucl Med Biol; 2015 Mar; 42(3):256-62. PubMed ID: 25516099
[TBL] [Abstract][Full Text] [Related]
15. Site-specific labeling of 'second generation' annexin V with 99mTc(CO)3 for improved imaging of apoptosis in vivo.
De Saint-Hubert M; Mottaghy FM; Vunckx K; Nuyts J; Fonge H; Prinsen K; Stroobants S; Mortelmans L; Deckers N; Hofstra L; Reutelingsperger CP; Verbruggen A; Rattat D
Bioorg Med Chem; 2010 Feb; 18(3):1356-63. PubMed ID: 20053567
[TBL] [Abstract][Full Text] [Related]
16. Preclinical validation of 99mTc-annexin A5-128 in experimental autoimmune myocarditis and infective endocarditis: comparison with 99mTc-HYNIC-annexin A5.
Benali K; Louedec L; Azzouna RB; Merceron O; Nassar P; Al Shoukr F; Petiet A; Barbato D; Michel JB; Sarda-Mantel L; Le Guludec D; Rouzet F
Mol Imaging; 2014; 13():. PubMed ID: 25431156
[TBL] [Abstract][Full Text] [Related]
17. Optimization of the preparation of 99mTc-labeled Hynic-derivatized Annexin V for human use.
Verbeke K; Kieffer D; Vanderheyden JL; Reutelingsperger C; Steinmetz N; Green A; Verbruggen A
Nucl Med Biol; 2003 Oct; 30(7):771-8. PubMed ID: 14499336
[TBL] [Abstract][Full Text] [Related]
18. Lys and Arg in UBI: a specific site for a stable Tc-99m complex?
Meléndez-Alafort L; Ramírez Fde M; Ferro-Flores G; Arteaga de Murphy C; Pedraza-López M; Hnatowich DJ
Nucl Med Biol; 2003 Aug; 30(6):605-15. PubMed ID: 12900286
[TBL] [Abstract][Full Text] [Related]
19. Phosphine-containing HYNIC derivatives as potential bifunctional chelators for (99m)Tc-labeling of small biomolecules.
Purohit A; Liu S; Casebier D; Edwards DS
Bioconjug Chem; 2003; 14(4):720-7. PubMed ID: 12862424
[TBL] [Abstract][Full Text] [Related]
20. Prolonged high-fat feeding enhances aortic 18F-FDG and 99mTc-annexin A5 uptake in apolipoprotein E-deficient and wild-type C57BL/6J mice.
Zhao Y; Kuge Y; Zhao S; Strauss HW; Blankenberg FG; Tamaki N
J Nucl Med; 2008 Oct; 49(10):1707-14. PubMed ID: 18794270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
